European Commission gives conditional OK for Biogen Idecs MS drug Fampyra
Links shared publicly online about this topic.
- 124total visits
European Commission gives conditional OK for Biogen Idecs MS drug Fampyra
{thePharmaLetter via BioPortfolio} The European subsidiary of US biotech firm Biogen Idec (Nasdaq: BIIB) has received conditional approval from the European Com...
View full resource at bioportfolio.com
Most Recently Shared on July 26, 2011 at 10:20 am By:
BioPortfolio News European Commission gives conditional OK for Biogen Idecs MS drug Fampyra: T... http://bit.ly/pALBrQ BioPortfolio News
Advertisement
